The price of pralatinib varies significantly depending on the drug version, strength, whether it is covered by medical insurance, and the purchase cha···【Read More】
Update: 2026-03-24Source: Haiou HealthViews: 83
Tepotinib use must strictly adhere to individualized treatment principles. The dosage and administration method should be determined by a specialist p···【Read More】
Update: 2026-03-23Source: Haiou HealthViews: 93
CStone Pharmaceuticals partner Blueprint Medicines recently announced that it has submitted a New Drug Application (NDA) to the US Food and Drug Admin···【Read More】
Update: 2026-03-23Source: Haiou HealthViews: 83
Blueprint Medicines recently announced that the U.S. Food and Drug Administration (FDA) has approved Gavreto (pralsetinib), a precision oncology drug,···【Read More】
Update: 2026-03-23Source: Haiou HealthViews: 86
Recently, the U.S. Food and Drug Administration (FDA) approved Gavreto (pralsetinib) capsules, a precision oncology drug and RET kinase inhibitor, for···【Read More】
Update: 2026-03-23Source: Haiou HealthViews: 83
China's National Medical Products Administration (NMPA) recently approved Prugihua® (pralsetinib capsules) as a Class 1 New Drug Application for t···【Read More】
Update: 2026-03-23Source: Haiou HealthViews: 104
The U.S. Food and Drug Administration (FDA) announced on August 9 that it has fully approved Gavreto (pralsetinib) for the treatment of adult patients···【Read More】
Update: 2026-03-23Source: Haiou HealthViews: 97
Last Friday, the UK's National Institute for Health and Care Evaluation (NICE) reversed its earlier rejection of AstraZeneca's lung cancer the···【Read More】
Update: 2026-03-23Source: Haiou HealthViews: 102
AstraZeneca recently announced that its supplemental New Drug Application (sNDA) for Tagrisso (osimertinib), an epidermal growth factor receptor (EGFR···【Read More】
Update: 2026-03-23Source: Haiou HealthViews: 93
The U.S. Food and Drug Administration (FDA) has approved TAGRISSO (osimertinib) for first-line treatment of patients with metastatic non-small cell lu···【Read More】
Update: 2026-03-23Source: Haiou HealthViews: 98
AstraZeneca announced yesterday that the U.S. Food and Drug Administration (FDA) has approved its epidermal growth factor receptor (EGFR) tyrosine kin···【Read More】
Update: 2026-03-23Source: Haiou HealthViews: 93
Certain medications may interact with binimetinib, including prescription drugs, over-the-counter medicines, vitamins, and herbal supplements. Inform ···【Read More】
Update: 2026-03-23Source: Haiou HealthViews: 86
Follow your physician’s guidance regarding any restrictions on food, beverages, or physical activity.【Read More】
Update: 2026-03-23Source: Haiou HealthViews: 87
Seek immediate medical assistance or contact the Poison Control Center hotline.【Read More】
Update: 2026-03-23Source: Haiou HealthViews: 89
Take the medication as soon as you remember. However, skip the missed dose if your next scheduled dose is due within 6 hours. Do not take a double dos···【Read More】
Update: 2026-03-23Source: Haiou HealthViews: 88
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos



